Home/Secura Bio/Chip R. Romp, MBA

CR

Chip R. Romp, MBA

Chief Executive Officer

Therapeutic Areas

Oncology Hematologic Malignancies

Secura Bio Pipeline

Drug	Indication	Phase
Duvelisib (COPIKTRA)	Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL); Relapsed/Refractory Follicular Lymphoma (FL)	Approved

Leadership Team at Secura Bio

Will Brown, MBA

Chief Financial Officer & Chief Operating Officer

Juan Estruch, Ph.D., MBA

Head of Corporate Development

View full Secura Bio profile